Cardiovascular Therapeutics

Scope & Guideline

Advancing Cardiovascular Care Through Open Access Research

Introduction

Welcome to the Cardiovascular Therapeutics information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cardiovascular Therapeutics, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1755-5914
PublisherWILEY-HINDAWI
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2008 to 2024
AbbreviationCARDIOVASC THER / Cardiovasc. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON WIT 5HE, ENGLAND

Aims and Scopes

Cardiovascular Therapeutics aims to advance the field of cardiovascular medicine through innovative research, clinical trials, and therapeutic advancements. The journal focuses on a wide range of topics related to cardiovascular diseases, therapies, and health outcomes, providing a platform for researchers and clinicians to share their findings.
  1. Cardiovascular Risk Assessment and Management:
    The journal publishes studies focusing on the assessment of cardiovascular risk factors, including novel biomarkers and risk prediction models, to enhance the management and prevention of cardiovascular diseases.
  2. Therapeutic Interventions and Clinical Trials:
    A significant emphasis is placed on clinical trials evaluating the efficacy and safety of new therapeutic interventions, including pharmacological treatments, surgical procedures, and lifestyle modifications.
  3. Pathophysiology and Mechanistic Insights:
    Research articles delve into the underlying mechanisms of cardiovascular diseases, exploring cellular and molecular pathways that contribute to conditions such as myocardial infarction, heart failure, and atherosclerosis.
  4. Rehabilitation and Exercise Therapy:
    The journal highlights studies that assess the role of rehabilitation strategies, including exercise therapy and lifestyle interventions, in improving outcomes for patients with cardiovascular conditions.
  5. Emerging Therapies and Natural Products:
    There is a growing interest in the exploration of natural products and alternative therapies for cardiovascular diseases, with studies investigating their potential therapeutic roles and mechanisms of action.
  6. Public Health and Epidemiological Studies:
    Cardiovascular Therapeutics also prioritizes research addressing public health aspects, epidemiological trends, and the socioeconomic impact of cardiovascular diseases.
Recent publications in Cardiovascular Therapeutics have highlighted several trending and emerging themes that reflect the evolving landscape of cardiovascular research. These themes are gaining traction and may represent future directions for the field.
  1. Biomarkers for Cardiovascular Diseases:
    An increasing number of studies focus on identifying and validating novel biomarkers for cardiovascular diseases, particularly in heart failure and atherosclerosis, which can enhance early diagnosis and treatment.
  2. Impact of COVID-19 on Cardiovascular Health:
    Research examining the implications of COVID-19 on cardiovascular health, including the effects of viral infections on existing cardiovascular conditions, has surged, showcasing the pandemic's influence on cardiovascular research.
  3. Integrative and Holistic Approaches to Treatment:
    Emerging interest in integrative therapies, such as meditation, yoga, and lifestyle modifications, reflects a trend towards holistic approaches to cardiovascular health, emphasizing the importance of mental and physical well-being.
  4. Advanced Imaging Techniques and Diagnostics:
    There is a notable trend towards the utilization of advanced imaging techniques for better diagnosis and management of cardiovascular diseases, facilitating more precise interventions.
  5. Artificial Intelligence and Machine Learning in Cardiovascular Research:
    The application of AI and machine learning methods in cardiovascular research is rapidly growing, particularly in risk prediction models and personalized treatment strategies, marking a significant technological advancement in the field.

Declining or Waning

While the journal continues to explore a wide array of cardiovascular topics, certain themes appear to be declining in prominence. This may reflect shifts in research focus or advancements in understanding that have led to reduced interest in specific areas.
  1. Traditional Risk Factor Studies:
    Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has decreased as newer methodologies and biomarkers gain traction in risk assessment.
  2. Pharmacogenomics in Cardiovascular Therapy:
    There has been a waning interest in studies solely dedicated to pharmacogenomic profiling for cardiovascular drug responses, possibly due to advancements in personalized medicine that integrate broader genetic and environmental factors.
  3. Basic Science Studies without Clinical Relevance:
    The journal has seen fewer submissions of basic science studies that do not translate into clinical applications, indicating a preference for research with direct implications for patient care.

Similar Journals

International Heart Journal

Pioneering Research for Heart Health Innovation
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Cardiology in Review

Exploring the forefront of cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1061-5377Frequency: 6 issues/year

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.

European Journal of Preventive Cardiology

Championing excellence in preventive cardiology research.
Publisher: OXFORD UNIV PRESSISSN: 2047-4873Frequency: 18 issues/year

The European Journal of Preventive Cardiology, published by Oxford University Press, is a leading international journal dedicated to the field of cardiology and cardiovascular medicine. With an impact factor that underscores its prestige—ranking in the top quartile (Q1) of both cardiology and epidemiology categories—the journal serves as a critical resource for researchers and practitioners seeking to advance their understanding of preventive strategies in cardiovascular health. Since its inception in 1999, it has provided a platform for high-quality research and reviews that address the epidemiology of cardiovascular diseases, risk factor management, and innovative prevention methodologies. Notably, it currently ranks #21 out of 387 in Medicine - Cardiology and #13 out of 148 in Medicine - Epidemiology according to Scopus, highlighting its influential position in these essential biomedical fields. The journal also provides open access options, allowing both readers and authors the opportunity to engage with groundbreaking research and enhance the dissemination of knowledge. With a commitment to excellence, the European Journal of Preventive Cardiology is an invaluable asset for those dedicated to the prevention of cardiovascular diseases.

Journal of the Practice of Cardiovascular Sciences

Pioneering Insights for Cardiovascular Excellence
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

Anatolian Journal of Cardiology

Exploring Innovative Pathways in Cardiovascular Medicine.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Cardiovascular Diagnosis and Therapy

Elevating Standards in Cardiovascular Medicine and Research
Publisher: AME PUBLISHING COMPANYISSN: 2223-3652Frequency: 6 issues/year

Cardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.

CJC Open

Unlocking the potential of open access in heart health.
Publisher: ELSEVIERISSN: 2589-790XFrequency:

CJC Open is a leading open access journal published by Elsevier, focused on advancing the fields of Cardiology and Cardiovascular Medicine. Since its inception in 2019, the journal has committed to disseminating high-quality research and groundbreaking advancements in cardiovascular health. With its ISSN 2589-790X and an impressive Q2 ranking in its field, CJC Open aims to foster collaboration and communication among researchers, healthcare professionals, and students by providing a platform for innovative studies, reviews, and insights. The journal is indexed in Scopus, currently ranking at #191 out of 387 in its category, underscoring its relevance and impact in the academic community. As an open access journal, CJC Open ensures that research findings are widely available, promoting greater visibility and readership. Scientists and practitioners alike are encouraged to submit their work, further enriching the discourse in cardiovascular research. With a focus on quality and accessibility, CJC Open is poised to make significant contributions to the field through 2024 and beyond.

CIRCULATION

Exploring the Frontiers of Cardiovascular Medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

PROGRESS IN CARDIOVASCULAR DISEASES

Pioneering Research for a Healthier Heart
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevating Cardiac Science Through Innovative Insights
Publisher: ELSEVIER SCIENCE INCISSN: 0735-1097Frequency: 50 issues/year

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, the esteemed publication of Elsevier Science Inc, stands as a premier platform for advancing knowledge in the field of cardiology and cardiovascular medicine. With an impressive impact factor reflecting its prominence—ranked Q1 in its category for 2023 and occupying the 4th position out of 387 in the Scopus listings, firmly placing it in the 99th percentile—this journal is essential for researchers, clinicians, and students alike. Since its inception in 1983, it has continuously provided a vital space for high-quality research and innovative clinical practices, driving forward our understanding of cardiovascular health. While access options are not open, the value of the cutting-edge articles published here cannot be overstated, as they foster collaboration and inform better patient care across the globe. As part of its ongoing commitment to excellence, the journal solicits submissions of original research, reviews, and clinical studies that contribute meaningfully to the field and engage its diverse readership.